Patients with inflammatory bowel disease may benefit from cannabis-based drugs, UK scientists believe.
The Bath University team found people with the gut disorder had an abundant number of a type of cannabinoid receptors in their body.
They believe this is part of the body’s attempt to dampen down the inflammation and that giving a drug that binds to these receptors could boost this.
Their findings appear in the journal Gastroenterology.
Complete article:
http://news.bbc.co.uk/2/hi/health/4728605.stm